|

Bomedemstat Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: IMG-7289, MK-3543

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Terrence J Bradley, MD1
  • Merck Sharp & Dohme LLC1

Indications

  • Cancer2
  • Thrombocythemia, Essential1
  • Post-essential Thrombocythemia Myelofibrosis1
  • Post-polycythemia Vera Myelofibrosis1
  • Acute Myeloid Leukemia, in Relapse1

Miami, Florida1 trial

Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia

University of Miami

Phase 1

Ann Arbor, Michigan1 trial

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

University of Michigan ( Site 6000)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.